Perspective Therapeutics Inc (CATX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione Frazionamento azionario

Perspective Therapeutics Inc Borsa (CATX) Ultime notizie

Perspective Therapeutics Inc (CATX)

Perspective Therapeutics Inc Borsa (CATX) Ultime notizie

Perspective Therapeutics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Perspective Therapeutics to Participate in Upcoming Investor Conferences - bitget.com

Perspective Therapeutics Advances First-in-Class 212Pb Radiopharmaceuticals for Solid Tumor Oncology Treatment - Minichart

Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline - TipRanks

Perspective Therapeutics updates corporate presentation, expects Phase 1/2 data across three programs in 2026 - TradingView

Perspective Therapeutics (NYSE: CATX) spotlights 212Pb radiopharmaceutical cancer pipeline - Stock Titan

Revenue Check: Can Perspective Therapeutics Inc grow without dilution2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn

Analyst Upgrade: Can Perspective Therapeutics Inc expand into new marketsRisk Management & Weekly Hot Stock Watchlists - baoquankhu1.vn

Aug Analyst Calls: What is the next catalyst for Perspective Therapeutics IncGlobal Markets & Advanced Technical Analysis Signals - baoquankhu1.vn

Perspective Therapeutics Q1 EPS Raised by HC Wainwright - MarketBeat

Investment Recap: What is the next catalyst for Perspective Therapeutics IncMarket Growth Report & Risk Controlled Daily Plans - baoquankhu1.vn

H.C. Wainwright raises Perspective Therapeutics price target to $13 By Investing.com - Investing.com South Africa

CATX: HC Wainwright & Co. Raises Price Target to $13, Maintains Buy Rating | CATX Stock News - GuruFocus

H.C. Wainwright raises Perspective Therapeutics price target to $13 - Investing.com

Perspective Therapeutics (NYSEAMERICAN:CATX) Given New $13.00 Price Target at HC Wainwright - MarketBeat

Perspective Therapeutics, Inc.(NYSEAM:CATX) added to S&P Biotechnology Select Industry Index - marketscreener.com

Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX) - The Globe and Mail

If You Invested $1,000 in Perspective Therapeutics Inc (CATX) - Stock Titan

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

CATX Should I Buy - Intellectia AI

Perspective Therapeutics Q1 EPS Boosted by Brookline Cap M - MarketBeat

Jones Trading reiterates Perspective Therapeutics stock Buy rating By Investing.com - Investing.com India

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX) - The Globe and Mail

Jones Trading reiterates Perspective Therapeutics stock Buy rating - Investing.com

Perspective Therapeutics (CATX) Receives Analyst Rating Boost | CATX Stock News - GuruFocus

B. Riley Financial Issues Positive Forecast for Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Price - MarketBeat

Perspective Therapeutics (CATX) Receives Analyst Rating Boost | - GuruFocus

Perspective Therapeutics (CATX) Receives Boost from UBS with Rai - GuruFocus

Perspective Therapeutics price target raised to $13 from $11 at B. Riley - TipRanks

UBS Adjusts Price Target on Perspective Therapeutics to $8 From $7, Maintains Buy Rating - marketscreener.com

UBS Group Forecasts Strong Price Appreciation for Perspective Therapeutics (NYSEAMERICAN:CATX) Stock - MarketBeat

Perspective Therapeutics (CATX) Rating Reiterated by Wedbush | C - GuruFocus

Perspective Therapeutics (NYSEAMERICAN:CATX) Receives Outperform Rating from Wedbush - MarketBeat

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and IDEAYA Biosciences (IDYA) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT) - The Globe and Mail

B. Riley Raises Price Target on Perspective Therapeutics to $13 From $11, Keeps Buy Rating - marketscreener.com

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 - The Manila Times

Perspective Therapeutics (CATX) to Release Earnings on Wednesday - MarketBeat

RBC cuts Perspective Therapeutics stock price target on model updates By Investing.com - Investing.com Australia

Perspective Therapeutics Q4 2025 earnings preview - MSN

Truist reiterates Buy on Perspective Therapeutics stock By Investing.com - Investing.com Canada

BTIG Reiterates Buy Rating for CATX with $14 Price Target | CATX Stock News - GuruFocus

Royal Bank Of Canada Lowers Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target to $14.00 - MarketBeat

RBC Capital Lowers Price Target for CATX While Maintaining 'Outp - GuruFocus

Truist reiterates Buy on Perspective Therapeutics stock - Investing.com

RBC cuts Perspective Therapeutics stock price target on model updates - Investing.com

Perspective Therapeutics stock rating reiterated at Buy by BTIG - Investing.com South Africa

Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform By Investing.com - Investing.com South Africa

Simile a CATX